Ligand profile
MMM
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_05515 — Aminotransferase, class V domain-containing protein
Identifiers
Database identifiers and provenance.
- Ligand ID
MMM- PDB
2yri- UniProt (similar protein)
Q5SLX0- Target protein
- KP13_05515
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 169.8
- −1 ≤ LogP ≤ 5 -0.04
- MW ≤ 500 Da 348.2
- LogP ≤ 5 -0.04
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 169.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(c(c(cn1)COP(=O)(O)O)\C=N\[C@@](C)(CO)C(=O)O)OCc1c(c(c(cn1)COP(=O)(O)O)\C=N\[C@@](C)(CO)C(=O)O)O
InChI=1S/C12H17N2O8P/c1-7-10(16)9(4-14-12(2,6-15)11(17)18)8(3-13-7)5-22-23(19,20)21/h3-4,15-16H,5-6H2,1-2H3,(H,17,18)(H2,19,20,21)/b14-4+/t12-/m0/s1InChI=1S/C12H17N2O8P/c1-7-10(16)9(4-14-12(2,6-15)11(17)18)8(3-13-7)5-22-23(19,20)21/h3-4,15-16H,5-6H2,1-2H3,(H,17,18)(H2,19,20,21)/b14-4+/t12-/m0/s1
ASXDVUDIJQGHKR-DRRTZOGYSA-NASXDVUDIJQGHKR-DRRTZOGYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00266
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand MMM →
- PDB RCSB structure 2yri →
- UniProt UniProt Q5SLX0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “MMM”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05515.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 20
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).